Public trial registry of the CCC-Munich

Trial IELSG 32

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
IELSG 32
World
Full title
:

Randomized Ph II Trial on primary chemotherapy with high-dose Methotrexate and high-dose Cytarabine with or without Thiotepa, and with or without Rituximab, followed by brain irradiation vs. High-dose chemotherapy supported by autologous stem cells transplantation for immunocompetent patients with newly diagnosed primary CNS Lymphoma im Hämalog

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Chirurgisch,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Ulrich Keller 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier